We list hundreds of Clinical Trials about "18FDG/AE" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.
More Information about "18FDG/AE" on BioPortfolio
We have published hundreds of 18FDG/AE news stories on BioPortfolio along with dozens of 18FDG/AE Clinical Trials and PubMed Articles about 18FDG/AE for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of 18FDG/AE Companies in our database. You can also find out about relevant 18FDG/AE Drugs and Medications on this site too.
18F-FDG produced in the MIRC NS has a similar safety profile to the same compound utilized elsewhere in that no significant adverse events will occur during observation of the patients for 2 1/2 hours post injection of the tracer. It is also hypothesized that as this FDG produced by similar methodology and its quality assurance assessed as in another jurisdictions will have similar performance parameters in patients with focal lung pathology to that previously determined.